InsiderTrades

Form 4 for BIO BIO-RAD LABORATORIES, INC.

Accepted 2024-10-22 00:00:00 ET · period of report 2024-10-20 · accession 0001062993-24-017850 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-10-22 2024-10-20 BIO EVRAN SEDAT EVP, Gbl Supply Chain F - Tax $346.37 -335 853.14 -28% -$116.0K
D 2024-10-22 2024-10-20 BIO EVRAN SEDAT EVP, Gbl Supply Chain M - OptEx $0.00 +1,044 1,188 +724% $0
D 2024-10-22 2024-10-20 BIO EVRAN SEDAT EVP, Gbl Supply Chain M - OptEx $0.00 -1,044 3,132 -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Bio-Rad A Common Stock 2024-10-20 F D 335 $346.37 853.14 D — —
2 Common Bio-Rad A Common Stock 2024-10-20 M A 1,044 $0.00 1,188.14 D — — (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. (F2) Includes 49.0480, 41.3870 and 33.7050 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 12/31/2023, 03/31/2024 and 06/30/2024, respectively.
3 Derivative Restricted Stock Units 2024-10-20 M D 1,044 $0.00 3,132 D $0.00 · — to — 1,044 Bio-Rad A Common Stock (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F4) On October 20, 2023, the reporting person was granted 4,176 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.